Can we confidently use ketamine as a clinical treatment for depression?

Lancet Psychiatry. 2018 Jan;5(1):11-12. doi: 10.1016/S2215-0366(17)30480-7.

Author

Affiliation

¹ School of Psychiatry, University of New South Wales, Sydney, NSW, Australia; St George Hospital, Sydney, NSW, Australia; Black Dog Institute, Randwick, Sydney, NSW 2031, Australia. Electronic address: colleen.loo@unsw.edu.au.

PMID: 29277196
DOI: 10.1016/S2215-0366(17)30480-7

No abstract available

Publication types

Editorial

MeSH terms

Anesthetics, Dissociative / administration & dosage
Anesthetics, Dissociative / adverse effects
Antidepressive Agents / administration & dosage
Antidepressive Agents / adverse effects
Depressive Disorder, Treatment-Resistant / drug therapy*
Dose-Response Relationship, Drug
Drug Administration Schedule
Humans
Ketamine* / administration & dosage
Ketamine* / adverse effects
Long Term Adverse Effects / chemically induced
Long Term Adverse Effects / diagnosis
Long Term Adverse Effects / prevention & control
Needs Assessment
Treatment Outcome

Substances

Anesthetics, Dissociative
Antidepressive Agents
Ketamine